Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 6Lymphoma 5Multiple Myeloma 3Waldenstrom Macroglobulinemia 2Lymphoma, Follicular 2Leukemia 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Burkitt Lymphoma 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 41Radiotherapy 32Fluorouracil 14Paclitaxel 13Docetaxel 12Cetuximab 12Radiotherapy, Intensity-Modulated 9Carboplatin 8Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 4Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Chemotherapy, Adjuvant 3vandetanib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiosurgery 2Pilocarpine 2Panitumumab 2Neoadjuvant Therapy 2Lapatinib 2Isotretinoin 2In Situ Hybridization 2Fluorodeoxyglucose F18 2Filgrastim 2Epoetin Alfa 2Drug Therapy 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Head and Neck Neoplasms × Interferon-alpha × Clear all
NCT00054561 2023-06-15

Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡